About Biontex
Biontex is a company based in Munchen (Germany) founded in 1997. It operates as a B2B and D2C. Biontex offers products and services including K4® Transfection System, K2® Transfection System, METAFECTENE® EASY+, METAFECTENE® SI+, and MycoSPY®. Biontex operates in a competitive market with competitors including BioLife Solutions, RoosterBio, Shanghai Doning Biotechnology, Polyplus Transfection and ArunA Bio, among others.
- Headquarter Munchen, Germany
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biontex.com/america
- Legal Name Biontex Laboratories Gmbh
Products & Services of Biontex
Biontex offers a comprehensive portfolio of products and services, including K4® Transfection System, K2® Transfection System, METAFECTENE® EASY+, METAFECTENE® SI+, and MycoSPY®.
Efficient system for gene transfer in cell research
Enhances adenoviral transduction for cell studies
Simplifies transfection for various cell types
Supports siRNA delivery in genetic experiments
Detects mycoplasma contamination in cultures
Facilitates protein delivery for research applications
Competitors of Biontex
Biontex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioLife Solutions, RoosterBio, Shanghai Doning Biotechnology, Polyplus Transfection and ArunA Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biolifesolutions.com | 1987 | Bothell, United States | – | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | |
| roosterbio.com | 2012 | Frederick, United States | $38.41M | 69 | Developer of human mesenchymal stem cells and extracellular vesicles | |
| duoningbio.com | 2005 | Shanghai, China | $14.88M | – | Serum-free cell culture media is supplied to biopharmaceutical industries. | |
| polyplus-transfection.com | 2001 | Illkirch Graffenstaden, France | $3.23M | – | Transfection Solutions for Healthcare and Life Sciences organizations | |
| arunabio.com | 2017 | Athens, United States | $38.51M | – | Neural exosome platform is developed for neurodegenerative disease therapeutics. | |
| biotangents.co.uk | 2015 | Edinburgh, United Kingdom | $5.62M | 13 | Veterinary diagnostics products are developed for bovine viral diarrhea testing. | |
| fabricnano.com | 2018 | London, United Kingdom | $22.6M | 12 | DNA-based flow reactors are developed for biochemical production. | |
| mirusbio.com | 1995 | Madison, United States | – | 33 | Developer of transfection reagents and electroporation products | |
| idtdna.com | 1987 | Coralville, United States | – | – | Provider of oligonucleotide-based reagents and kits | |
| predictimmune.com | 2017 | Cambridge, United Kingdom | $18.32M | 15 | Tools for diagnosing immune-mediated inflammatory diseases are developed. |
Detailed competitors of Biontex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biontex
Websites that share an audience with Biontex (biontex.com).
Websites whose visitors overlap most with Biontex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| eisbach.bio | 98% | 1.7K | #10,492,522 | View details | |
| mk2.bio | 97% | – | – | View details | |
| leukocare.com | 97% | 5.7K | #3,715,251 | View details | |
| sitoolsbiotech.com | 85% | 3.5K | – | View details | |
| tubulis.com | 85% | 19.5K | #1,280,536 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for Biontex
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Biontex
10 companies that operate in the same segment as Biontex (Transplant Medicine), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medical solutions for transplant patients are developed and provided. | 1998 | Brisbane, California, United States | USD 138.21 M | USD 379.81 M | 650 | |
Developer of organ transplantation technology | 1998 | Andover, Massachusetts, United States | USD 265.55 M | USD 605.49 M | 728 | |
Warm storage and transport systems for harvested organs are provided. | 2008 | Oxford, Oxfordshire, United Kingdom | USD 45.42 M | USD 1.36 M | 14 | |
Human tissue-based products are developed for vascular disease applications. | 2004 | Morrisville, United States | USD 424.76 M | USD 2.04 M | 220 | |
Next-generation medicines for CNS and immunological disorders are developed. | 2007 | New York, New York, United States | USD 4.45 M | USD 13.11 M | 81 | |
Breakthrough therapies are developed for blood diseases and infections. | 2014 | Buffalo, New York, United States | USD 1 M | – | 22 | |
Personalized skin tissue therapy is developed by CUTISS for surgeries. | 2017 | Zurich, Switzerland | USD 94.37 M | – | – | |
Game currency trading services are provided by Magenta Piman. | 2016 | Cambridge, Massachusetts, United States | USD 150.5 M | – | 75 | |
T regulatory cell therapies are developed for immunological diseases. | 2019 | London, England, United Kingdom | USD 344.25 M | – | – | |
Therapeutics for transplantation in autoimmune and neurodegenerative diseases are developed. | 2004 | Irvine, California, United States | USD 1.89 M | – | 31 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biontex
Biontex was founded in 1997.
Biontex is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Biontex Laboratories GmbH specializes in developing and supplying transfection reagents, proteofection tools, and mycoplasma-free cell culture products. These enable efficient gene transfer and cell manipulation for research purposes. Based in Munich, Germany, the company serves global regions through online sales and support. Their products cater to scientists and laboratories, focusing on reliable biotechnology applications.
Biontex's top competitors include FabricNano, RoosterBio and BioLife Solutions.
Biontex offers K4® Transfection System, K2® Transfection System, METAFECTENE® EASY+, METAFECTENE® SI+, and 2 more products and services.
Biontex operates through Biontex Laboratories Gmbh.